Adam Woodrow, President & Chief Commercial at Paratek Pharmaceuticals, Inc. (PRTK), sold 10,073 shares at $1.98 ($20K) on 2022-12-12, disclosed to the SEC on 2022-12-14.
Scheduled sale ($20k) by President & Chief Commercial under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.98 | 3,820 | $8K | 38.2% |
| 2 | $1.96 | 6,253 | $12K | 61.8% |
| Total | $1.97 avg | 10,073 | $20K | 100% |
| Filing → |
| PRTK | SELL | 2021-12-15 | $269K | — | Filing → |
| PRTK | SELL | 2021-08-18 | $56K | — | Filing → |
| PRTK | SELL | 2021-06-08 | $333K | — | Filing → |